Heart rate variability is decreased in chronic kidney disease but may improve with hemoglobin normalization

Journal of Nephrology

Volumn 21, Issue 1, 2008, Pages 45-52

  Furuland, Hans ^a   Linde, Torbjörn ^a   Englund, Anders ^b   Wikström, Björn ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anemia; Cardiac autonomic function; Chronic kidney disease; Epoetin; Heart rate variability; Hemoglobin; Left ventricular mass index

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; FERROUS SULFATE; HEMOGLOBIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; AUTONOMIC DYSFUNCTION; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; ELECTROCARDIOGRAM; FEMALE; GLOMERULUS FILTRATION RATE; HEART RATE VARIABILITY; HEMOGLOBIN BLOOD LEVEL; HOLTER MONITORING; HUMAN; HYPERTENSION; MALE; RR INTERVAL; BLOOD; BLOOD PRESSURE; CHRONIC DISEASE; HEART RATE; KIDNEY DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; AGED; ANEMIA; BLOOD PRESSURE; CHRONIC DISEASE; FEMALE; HEART RATE; HEMOGLOBINS; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED;

EID: 43249114164     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Cole CR, Lauer MS, Bigger JT. Clinical assessment of the autonomic nervous system. In: Topol EJ, ed. Textbook of Cardiovascular Medicine. Philadelphia, PA: Lippincott Williams & Wilkins; 2002:1615-1632.
2. Ewing DJ. Heart rate variability: an important new risk factor in patients following myocardial infarction. Clin Cardiol. 1991;14:683-685.
3. Mallamaci F, Zoccali C, Ciccarelli M, Briggs JD. Autonomic function in uremic patients treated by hemodialysis or CAPD and in transplant patients. Clin Nephrol. 1986;25:175-180.
4. Steinberg AA, Mars RL, Goldman DS, Percy RF. Effect of end-stage renal disease on decreased heart rate variability. Am J Cardiol. 1998;82:1156-1158, A1110.
5. Hathaway DK, Cashion AK, Milstead EJ, et al. Autonomic dysregulation in patients awaiting kidney transplantation. Am J Kidney Dis. 1998;32:221-229.
6. Kurata C, Uehara A, Sugi T, et al. Cardiac autonomic neuropathy in patients with chronic renal failure on hemodialysis. Nephron. 2000;84:312-319.
7. Di Leo R, Vita G, Messina C, Savica V. Autonomic function in elderly uremics studied by spectral analysis of heart rate. Kidney Int. 2005;67:1521-1525.
8. Dougherty CM, Burr RL. Comparison of heart rate variability in survivors and nonsurvivors of sudden cardiac arrest. Am J Cardiol. 1992;70:441-448.
9. Algra A, Tijssen JG, Roelandt JR, Pool J, Lubsen J. Heart rate variability from 24-hour electrocardiography and the 2-year risk for sudden death. Circulation. 1993;88:180-185.
10. Hayano J, Takahashi H, Toriyama T, et al. Prognostic value of heart rate variability during long-term follow-up in chronic haemodialysis patients with end-stage renal disease. Nephrol Dial Transplant. 1999;14:1480-1488.
11. Fukuta H, Hayano J, Ishihara S, et al. Prognostic value of heart rate variability in patients with end-stage renal disease on chronic haemodialysis. Nephrol Dial Transplant. 2003;18:318-325.
12. Neumann J, Ligtenberg G, Klein II, Koomans HA, Blankestijn PJ. Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment. Kidney Int. 2004;65:1568-1576.
13. Burger AJ, D'Elia JA, Weinrauch LA, Lerman I, Gaur A. Marked abnormalities in heart rate variability are associated with progressive deterioration of renal function in type I diabetic patients with overt nephropathy. Int J Cardiol. 2002;86:281-287.
14. Navarro X, Kennedy WR, Loewenson RB, Sutherland DE. Influence of pancreas transplantation on cardiorespiratory reflexes, nerve conduction, and mortality in diabetes mellitus. Diabetes. 1990;39:802-806.
15. Tamura K, Tsuji H, Nishiue T, Yajima I, Higashi T, Iwasaka T. Determinants of heart rate variability in chronic hemodialysis patients. Am J Kidney Dis. 1998;31:602-606.
16. Gehi A, Ix J, Shlipak M, Pipkin SS, Whooley MA. Relation of anemia to low heart rate variability in patients with coronary heart disease (from the Heart and Soul Study). Am J Cardiol 2005;95:1474-1477.
17. Cameron JS. European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant. 1999;14:61-65.
18. Casadevall N, Nataf J, Viron B, et al. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med. 2002;346:469-475.
19. Eckardt K-U, Casadevali N. Pure red-cell aplasia due to anti-erythropoietin antibodies. Nephrol Dial Transplant. 2003;18:865-869.
20. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
21. Sahn D, De Maria A, Kisso J, Weyman A. The Committee on M-mode Standardization of the American Society of Echocardiography: recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072-1083.
22. Devereux RB. Detection of left ventricular hypertrophy by M-mode echocardiography: anatomic validation, standardization, and comparison to other methods. Hypertension. 1987;9:II9-26.
23. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 1996;93:1043-1065.
24. Levey A. Part 4: definition and classification of stages of chronic kidney disease. Am J Kidney Dis. 2002;39:S46-S75.
25. Deligiannis A, Kouidi E, Tourkantonis A. Effects of physical training on heart rate variability in patients on hemodialysis. Am J Cardiol. 1999;84:197-202.
26. Chan CT, Hanly P, Gabor J, Picton P, Pierratos A, Floras JS. Impact of nocturnal hemodialysis on the variability of heart rate and duration of hypoxemia during sleep. Kidney Int. 2004;65:661-665.
27. Laaksonen S, Voipio-Pulkki L, Erkinjuntti M, Asola M, Falck B. Does dialysis therapy improve autonomic and peripheral nervous system abnormalities in chronic uraemia? J Intern Med. 2000;248:21-26.
28. Rubinger D, Revis N, Pollak A, Luria MH, Sapoznikov D. Predictors of haemodynamic instability and heart rate variability during haemodialysis. Nephrol Dial Transplant. 2004;19:2053-2060.
29. Cavalcanti S, Seven S, Chiari L, et al. Autonomic nervous function during haemodialysis assessed by spectral analysis of heart-rate variability. Clin Sci (Lond) 1997;92:351-359.
30. Karayaylali I, San M, Kudaiberdieva G, et al. Heart rate variability, left ventricular functions, and cardiac autonomic neuropathy in patients undergoing chronic hemodialysis. Ren Fail. 2003;25:845-853.
31. La Rovere MT, Pinna GD, Maestri R, et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation. 2003;107:565-570.
32. Rubinger D, Sapoznikov D, Pollak A, Popovtzer MM, Luria MH. Heart rate variability during chronic hemodialysis and after renal transplantation: studies in patients without and with systemic amyloidosis. J Am Soc Nephrol. 1999;10:1972-1981.
33. Reyners AK, Hazenberg BPC, Reitsma WD, Smit AJ. Heart rate variability as a predictor of mortality in patients with AA and AL amyloidosis. Eur Heart J. 2002;23:157-161.
34. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32:S112-S119.
35. Cook JR, Bigger JT Jr, Kleiger RE, Fleiss JL, Steinman RC, Rolnitzky LM. Effect of atenolol and diltiazem on heart period variability in normal persons. J Am Coll Cardiol. 1991;17:480-484.
36. Schroeder EB, Liao D, Chambless LE, Prineas RJ, Evans GW, Heiss G. Hypertension, blood pressure, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. Hypertension. 2003;42:1106-1111.
37. Facchini M, Malfatto G, Sala L, et al. Changes of autonomic cardiac profile after a 3-week integrated body weight reduction program in severely obese patients. J Endocrinol Invest. 2003;26:138-142.
38. Nishimura M, Hashimoto T, Kobayashi H, et al. Association between cardiovascular autonomic neuropathy and left ventricular hypertrophy in diabetic haemodialysis patients. Nephrol Dial Transplant. 2004;19:2532-2538.
39. Nolan J, Batin PD, Andrews R, et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation. 1998;98:1510-1516.